New data confirm EFSA’s previous conclusion that bisphenol A (BPA) might affect the immune system in animals, but the evidence is too limited to draw any conclusions for human health.
Following a request from the Dutch Ministry of Health, Welfare and Sport, EFSA’s experts reviewed two studies by Ménard et al. (unpublished at the time of EFSA’s last comprehensive evaluation of BPA) and concluded that there were key limitations in the way they were designed and carried out. Furthermore, the data from the studies were too variable to use for setting a new tolerable daily intake (TDI) for BPA.
Click here to read the full article.